TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 14,928 | 18,273 | 16,298 |
Financial expenses | 32 | 12 | 16 |
Earnings before taxes | 106 | 2,983 | 1,770 |
EBITDA | 398 | 3,229 | 1,993 |
Total assets | 16,688 | 16,474 | 7,544 |
Current assets | 8,960 | 8,207 | 6,659 |
Current liabilities | 2,875 | 2,381 | 2,298 |
Equity capital | 10,835 | 11,716 | 3,240 |
- share capital | 134 | 145 | 148 |
Employees (average) | 14 | 14 | 14 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 64.9% | 71.1% | 42.9% |
Turnover per employee | 1,066 | 1,305 | 1,164 |
Profit as a percentage of turnover | 0.7% | 16.3% | 10.9% |
Return on assets (ROA) | 0.8% | 18.2% | 23.7% |
Current ratio | 311.7% | 344.7% | 289.8% |
Return on equity (ROE) | 1.0% | 25.5% | 54.6% |
Change turnover | -1,865 | 2,283 | -1,447 |
Change turnover % | -11% | 14% | -8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.